{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "DFT", "SARS-CoV-2", "molecular docking", "natural products", "papain-like protease", "structural similarity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36143445", "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "09"}], "Language": ["eng"], "ELocationID": ["1407", "10.3390/life12091407"], "Journal": {"ISSN": "2075-1729", "JournalIssue": {"Volume": "12", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "09"}}, "Title": "Life (Basel, Switzerland)", "ISOAbbreviation": "Life (Basel)"}, "ArticleTitle": "Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach.", "Abstract": {"AbstractText": ["As an extension of our research against COVID-19, a multiphase <i>in silico</i> approach was applied in the selection of the three most common inhibitors (Glycyrrhizoflavone (<b>76</b>), Arctigenin (<b>94</b>)<b>,</b> and Thiangazole (<b>298</b>)) against papain-like protease, PLpro (PDB ID: 4OW0), among 310 metabolites of natural origin. All compounds of the exam set were reported as antivirals. The structural similarity between the examined compound set and <b>S88</b>, the co-crystallized ligand of PLpro, was examined through structural similarity and fingerprint studies. The two experiments pointed to Brevicollin (<b>28</b>), Cryptopleurine (<b>41</b>), Columbamine (<b>46</b>), Palmatine (<b>47</b>), Glycyrrhizoflavone (<b>76</b>), Licochalcone A (<b>87</b>), Arctigenin (<b>94</b>), Termilignan (<b>98</b>), Anolignan B (<b>99</b>), 4,5-dihydroxy-6\u2033-deoxybromotopsentin (<b>192</b>), Dercitin (<b>193</b>), Tryptanthrin (<b>200</b>), 6-Cyano-5-methoxy-12-methylindolo [2, 3A] carbazole (<b>211</b>), Thiangazole (<b>298</b>), and Phenoxan (<b>300</b>). The binding ability against PLpro was screened through molecular docking, disclosing the favorable binding modes of six metabolites. ADMET studies expected molecules <b>28</b>, <b>76</b>, <b>94</b>, <b>200</b>, and <b>298</b> as the most favorable metabolites. Then, molecules <b>76</b>, <b>94</b>, and <b>298</b> were chosen through <i>in silico</i> toxicity studies. Finally, DFT studies were carried out on glycyrrhizoflavone (<b>76</b>) and indicated a high level of similarity in the molecular orbital analysis. The obtained data can be used in further <i>in vitro</i> and <i>in vivo</i> studies to examine and confirm the inhibitory effect of the filtered metabolites against PLpro and SARS-CoV-2."]}, "AuthorList": [{"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0001-9202-1754"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Alesawy", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": ["0000-0002-5153-7399"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Saleh", "ForeName": "Abdulrahman M", "Initials": "AM"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}], "GrantList": [{"GrantID": "PNURSP2022R116", "Agency": "Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Life (Basel)", "NlmUniqueID": "101580444", "ISSNLinking": "2075-1729"}, "CoiStatement": "No conflict of interest to be declared."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 10 September 2021)].  Available online:  https://covid19.who.int/"}, {"Citation": "Engel T. Basic overview of chemoinformatics. J. Chem. Inf. Modeling. 2006;46:2267\u20132277. doi: 10.1021/ci600234z.", "ArticleIdList": ["10.1021/ci600234z", "17125169"]}, {"Citation": "Xu J., Hagler A. Chemoinformatics and drug discovery. Molecules. 2002;7:566\u2013600. doi: 10.3390/70800566.", "ArticleIdList": ["10.3390/70800566"]}, {"Citation": "Jalmakhanbetova R.I., Suleimen Y.M., Oyama M., Elkaeed E.B., Eissa I., Suleimen R.N., Metwaly A.M., Ishmuratova M.Y. Isolation and In Silico Anti-COVID-19 Main Protease (Mpro) Activities of Flavonoids and a Sesquiterpene Lactone from Artemisia sublessingiana. J. Chem. 2021;2021:5547013. doi: 10.1155/2021/5547013.", "ArticleIdList": ["10.1155/2021/5547013"]}, {"Citation": "Koshak A.E., Koshak E.A. Nigella sativa L. as a potential phytotherapy for covid-19: A mini-review of in-silico studies. Curr. Ther. Res. 2020;93:100602. doi: 10.1016/j.curtheres.2020.100602.", "ArticleIdList": ["10.1016/j.curtheres.2020.100602", "PMC7445151", "32863400"]}, {"Citation": "Basu S., Ramaiah S., Anbarasu A. In-silico strategies to combat COVID-19: A comprehensive review. Biotechnol. Genet. Eng. Rev. 2021;37:64\u201381. doi: 10.1080/02648725.2021.1966920.", "ArticleIdList": ["10.1080/02648725.2021.1966920", "34470564"]}, {"Citation": "Lo Y.-C., Rensi S.E., Torng W., Altman R.B. Machine learning in chemoinformatics and drug discovery. Drug Discov. Today. 2018;23:1538\u20131546. doi: 10.1016/j.drudis.2018.05.010.", "ArticleIdList": ["10.1016/j.drudis.2018.05.010", "PMC6078794", "29750902"]}, {"Citation": "Zhang W., Pei J., Lai L. Computational multitarget drug design. J. Chem. Inf. Modeling. 2017;57:403\u2013412. doi: 10.1021/acs.jcim.6b00491.", "ArticleIdList": ["10.1021/acs.jcim.6b00491", "28166637"]}, {"Citation": "Youssef M.I., Zhou Y., Eissa I.H., Wang Y., Zhang J., Jiang L., Hu W., Qi J., Chen Z. Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochem. Int. 2020;138:104749. doi: 10.1016/j.neuint.2020.104749.", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "Kairys V., Baranauskiene L., Kazlauskiene M., Matulis D., Kazlauskas E. Binding affinity in drug design: Experimental and computational techniques. Expert Opin. Drug Discov. 2019;14:755\u2013768. doi: 10.1080/17460441.2019.1623202.", "ArticleIdList": ["10.1080/17460441.2019.1623202", "31146609"]}, {"Citation": "Al-Warhi T., El Kerdawy A.M., Aljaeed N., Ismael O.E., Ayyad R.R., Eldehna W.M., Abdel-Aziz H.A., Al-Ansary G.H. Synthesis, biological evaluation and in silico studies of certain oxindole\u2013indole conjugates as anticancer CDK inhibitors. Molecules. 2020;25:2031. doi: 10.3390/molecules25092031.", "ArticleIdList": ["10.3390/molecules25092031", "PMC7248897", "32349307"]}, {"Citation": "Sharma A.K., Srivastava G.N., Roy A., Sharma V.K. ToxiM: A toxicity prediction tool for small molecules developed using machine learning and chemoinformatics approaches. Front. Pharmacol. 2017;8:880. doi: 10.3389/fphar.2017.00880.", "ArticleIdList": ["10.3389/fphar.2017.00880", "PMC5714866", "29249969"]}, {"Citation": "Speck-Planche A., Cordeiro M.J.D.S. Simultaneous virtual prediction of anti-Escherichia coli activities and ADMET profiles: A chemoinformatic complementary approach for high-throughput screening. ACS Comb. Sci. 2014;16:78\u201384. doi: 10.1021/co400115s.", "ArticleIdList": ["10.1021/co400115s", "24383958"]}, {"Citation": "Flores-Holgu\u00edn N., Frau J., Glossman-Mitnik D. Conceptual DFT as a chemoinformatics tool for the study of the Taltobulin anticancer peptide. BMC Res. Notes. 2019;12:442. doi: 10.1186/s13104-019-4478-7.", "ArticleIdList": ["10.1186/s13104-019-4478-7", "PMC6642520", "31324267"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Eissa I.H., Elsehemy I.A., Mostafa A.E., Hegazy M.M., Afifi W.M., Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28:5823\u20135832. doi: 10.1016/j.sjbs.2021.06.044.", "ArticleIdList": ["10.1016/j.sjbs.2021.06.044", "PMC8459052", "34588897"]}, {"Citation": "Han X., Yang Y., Metwaly A.M., Xue Y., Shi Y., Dou D. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J. Ethnopharmacol. 2019;239:111942. doi: 10.1016/j.jep.2019.111942.", "ArticleIdList": ["10.1016/j.jep.2019.111942", "31075380"]}, {"Citation": "Ghildiyal R., Prakash V., Chaudhary V., Gupta V., Gabrani R. Plant-Derived Bioactives. Springer; Berlin/Heidelberg, Germany: 2020. Phytochemicals as antiviral agents: Recent updates; pp. 279\u2013295."}, {"Citation": "El Sayed K.A. Natural products as antiviral agents. Stud. Nat. Prod. Chem. 2000;24:473\u2013572."}, {"Citation": "Uzair B., Mahmood Z., Tabassum S. Antiviral activity of natural products extracted from marine organisms. BioImpacts. 2011;1:203.", "ArticleIdList": ["PMC3648973", "23678429"]}, {"Citation": "Owen L., Laird K., Shivkumar M. Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle. Lett. Appl. Microbiol. 2021 doi: 10.1111/lam.13637.", "ArticleIdList": ["10.1111/lam.13637", "34953146"]}, {"Citation": "Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657\u2013662. doi: 10.1038/s41586-020-2601-5.", "ArticleIdList": ["10.1038/s41586-020-2601-5", "PMC7116779", "32726803"]}, {"Citation": "B\u00e1ez-Santos Y.M., John S.E.S., Mesecar A.D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antivir. Res. 2015;115:21\u201338. doi: 10.1016/j.antiviral.2014.12.015.", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., Eissa I.H., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Eissa I.H., Khalifa M.M., Elkaeed E.B., Hafez E.E., Alsfouk A.A., Metwaly A.M. In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules. 2021;26:6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}, {"Citation": "Alesawy M.S., Elkaeed E.B., Alsfouk A.A., Metwaly A.M., Eissa I. In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-Like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies. Molecules. 2021;26:6593. doi: 10.3390/molecules26216593.", "ArticleIdList": ["10.3390/molecules26216593", "PMC8588135", "34771004"]}, {"Citation": "Eissa I.H., Alesawy M.S., Saleh A.M., Elkaeed E.B., Alsfouk B.A., El-Attar A.-A.M., Metwaly A.M. Ligand and structure-based in silico determination of the most promising SARS-CoV-2 nsp16-nsp10 2\u2032-o-Methyltransferase complex inhibitors among 3009 FDA approved drugs. Molecules. 2022;27:2287. doi: 10.3390/molecules27072287.", "ArticleIdList": ["10.3390/molecules27072287", "PMC9000629", "35408684"]}, {"Citation": "Elkaeed E.B., Eissa I.H., Elkady H., Abdelalim A., Alqaisi A.M., Alsfouk A.A., Elwan A., Metwaly A.M. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease. Int. J. Mol. Sci. 2022;23:8407. doi: 10.3390/ijms23158407.", "ArticleIdList": ["10.3390/ijms23158407", "PMC9369012", "35955547"]}, {"Citation": "Elkaeed E.B., Youssef F.S., Eissa I.H., Elkady H., Alsfouk A.A., Ashour M.L., El Hassab M.A., Abou-Seri S.M., Metwaly A.M. Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease. Int. J. Mol. Sci. 2022;23:6912. doi: 10.3390/ijms23136912.", "ArticleIdList": ["10.3390/ijms23136912", "PMC9266348", "35805916"]}, {"Citation": "Elkaeed E.B., Elkady H., Belal A., Alsfouk B.A., Ibrahim T.H., Abdelmoaty M., Arafa R.K., Metwaly A.M., Eissa I.H. Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes. 2022;10:530. doi: 10.3390/pr10030530.", "ArticleIdList": ["10.3390/pr10030530"]}, {"Citation": "Altamash T., Amhamed A., Aparicio S., Atilhan M. Effect of hydrogen bond donors and acceptors on CO2 absorption by deep eutectic solvents. Processes. 2020;8:1533."}, {"Citation": "Wan Y., Tian Y., Wang W., Gu S., Ju X., Liu G. In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches. RSC Adv. 2018;8:40529\u201340543. doi: 10.1039/C8RA06475J.", "ArticleIdList": ["10.1039/C8RA06475J", "PMC9091378", "35557880"]}, {"Citation": "Turchi M., Cai Q., Lian G. An evaluation of in-silico methods for predicting solute partition in multiphase complex fluids\u2013A case study of octanol/water partition coefficient. Chem. Eng. Sci. 2019;197:150\u2013158. doi: 10.1016/j.ces.2018.12.003.", "ArticleIdList": ["10.1016/j.ces.2018.12.003"]}, {"Citation": "Sullivan K.M., Enoch S.J., Ezendam J., Sewald K., Roggen E.L., Cochrane S. An adverse outcome pathway for sensitization of the respiratory tract by low-molecular-weight chemicals: Building evidence to support the utility of in vitro and in silico methods in a regulatory context. Appl. Vitr. Toxicol. 2017;3:213\u2013226. doi: 10.1089/aivt.2017.0010.", "ArticleIdList": ["10.1089/aivt.2017.0010"]}, {"Citation": "Escamilla-Guti\u00e9rrez A., Ribas-Aparicio R.M., C\u00f3rdova-Espinoza M.G., Castel\u00e1n-Vega J.A. In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets. Nucleosides Nucleotides Nucleic Acids. 2021;40:798\u2013807. doi: 10.1080/15257770.2021.1951754.", "ArticleIdList": ["10.1080/15257770.2021.1951754", "34323642"]}, {"Citation": "Kaushik A.C., Kumar A., Bharadwaj S., Chaudhary R., Sahi S. Bioinformatics Techniques for Drug Discovery. Springer; Berlin/Heidelberg, Germany: 2018. Ligand-Based Approach for In-silico Drug Designing; pp. 11\u201319."}, {"Citation": "Zhang H., Ren J.-X., Ma J.-X., Ding L. Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier. Mol. Divers. 2019;23:381\u2013392. doi: 10.1007/s11030-018-9882-8.", "ArticleIdList": ["10.1007/s11030-018-9882-8", "30294757"]}, {"Citation": "Burke B.J. Ph.D. Thesis. University of Illinois at Chicago, Health Sciences Center; Chicago, IL, USA: 1993. Developments in Molecular Shape Analysis to Establish Spatial Similarity among Flexible Molecules."}, {"Citation": "Briem H., Kuntz I.D. Molecular similarity based on DOCK-generated fingerprints. J. Med. Chem. 1996;39:3401\u20133408. doi: 10.1021/jm950800y.", "ArticleIdList": ["10.1021/jm950800y", "8765524"]}, {"Citation": "Chu H., He Q.-X., Wang J., Hu Y., Wang Y.-Q., Lin Z.-H. In silico design of novel benzohydroxamate-based compounds as inhibitors of histone deacetylase 6 based on 3D-QSAR, molecular docking, and molecular dynamics simulations. New J. Chem. 2020;44:21201\u201321210. doi: 10.1039/D0NJ04704J.", "ArticleIdList": ["10.1039/D0NJ04704J"]}, {"Citation": "Ieritano C., Campbell J.L., Hopkins W.S. Predicting differential ion mobility behaviour in silico using machine learning. Analyst. 2021;146:4737\u20134743. doi: 10.1039/D1AN00557J.", "ArticleIdList": ["10.1039/D1AN00557J", "34212943"]}, {"Citation": "Taha M., Ismail N.H., Ali M., Rashid U., Imran S., Uddin N., Khan K.M. Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies. Bioorganic Chem. 2017;71:192\u2013200. doi: 10.1016/j.bioorg.2017.02.005.", "ArticleIdList": ["10.1016/j.bioorg.2017.02.005", "28228228"]}, {"Citation": "Opo F.A.D.M., Rahman M.M., Ahammad F., Ahmed I., Bhuiyan M.A., Asiri A.M. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci. Rep. 2021;11:4049. doi: 10.1038/s41598-021-83626-x.", "ArticleIdList": ["10.1038/s41598-021-83626-x", "PMC7892887", "33603068"]}, {"Citation": "Wang J., Morin P., Wang W., Kollman P.A. Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J. Am. Chem. Soc. 2001;123:5221\u20135230. doi: 10.1021/ja003834q.", "ArticleIdList": ["10.1021/ja003834q", "11457384"]}, {"Citation": "Houston D.R., Walkinshaw M.D. Consensus docking: Improving the reliability of docking in a virtual screening context. J. Chem. Inf. Modeling. 2013;53:384\u2013390. doi: 10.1021/ci300399w.", "ArticleIdList": ["10.1021/ci300399w", "23351099"]}, {"Citation": "Nelson D., Cox M. Lehninger Principles of Biochemistry. 5th ed. WH Freeman and Company; New York, NY, USA: 2008. G protein-coupled receptors and second messengers; pp. 423\u2013439."}, {"Citation": "Malau N.D., Azzahra S.F. Journal of Physics: Conference Series. IOP Publishing; Bristol, UK: 2020. Molecular Docking Studies of Potential Quercetin 3,4\u2032-dimethyl ether 7-alpha-LArabinofuranosyl-(1-6)-glucoside as Inhibitor antimalaria; p. 012057."}, {"Citation": "Patel H., Dhangar K., Sonawane Y., Surana S., Karpoormath R., Thapliyal N., Shaikh M., Noolvi M., Jagtap R. In search of selective 11\u03b2-HSD type 1 inhibitors without nephrotoxicity: An approach to resolve the metabolic syndrome by virtual based screening. Arab. J. Chem. 2018;11:221\u2013232. doi: 10.1016/j.arabjc.2015.08.003.", "ArticleIdList": ["10.1016/j.arabjc.2015.08.003"]}, {"Citation": "Mannhold R., Kubinyi H., Folkers G. Pharmacokinetics and Metabolism in Drug Design. Volume 51 John Wiley & Sons; Hoboken, NJ, USA: 2012."}, {"Citation": "Klopman G., Stefan L.R., Saiakhov R.D. ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 2002;17:253\u2013263. doi: 10.1016/S0928-0987(02)00219-1.", "ArticleIdList": ["10.1016/S0928-0987(02)00219-1", "12453615"]}, {"Citation": "Roy P.P., Roy K. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors. Chem. Biol. Drug Des. 2009;73:442\u2013455. doi: 10.1111/j.1747-0285.2009.00791.x.", "ArticleIdList": ["10.1111/j.1747-0285.2009.00791.x", "19291105"]}, {"Citation": "Ghafourian T., Amin Z. QSAR models for the prediction of plasma protein binding. BioImpacts BI. 2013;3:21.", "ArticleIdList": ["PMC3648908", "23678466"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA  QSAR, ADMET and Predictive Toxicology.  [(accessed on 1 May 2020)].  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Venkatapathy R., Wang N.C.Y., Martin T.M., Harten P.F., Young D. Structure\u2013Activity Relationships for Carcinogenic Potential. Gen. Appl. Syst. Toxicol. 2009 doi: 10.1002/9780470744307.gat079.", "ArticleIdList": ["10.1002/9780470744307.gat079"]}, {"Citation": "Goodrnan G., Wilson R. Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Anal. 1992;12:525\u2013533. doi: 10.1111/j.1539-6924.1992.tb00709.x.", "ArticleIdList": ["10.1111/j.1539-6924.1992.tb00709.x", "1480798"]}, {"Citation": "Council N.R. Issues in Risk Assessment. National Academies Press (US); Washington, DC, USA: 1993. Correlation between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment."}, {"Citation": "Gonella Diaza R., Manganelli S., Esposito A., Roncaglioni A., Manganaro A., Benfenati E. Comparison of in silico tools for evaluating rat oral acute toxicity. SAR QSAR Environ. Res. 2015;26:1\u201327. doi: 10.1080/1062936X.2014.977819.", "ArticleIdList": ["10.1080/1062936X.2014.977819", "25567032"]}, {"Citation": "Pizzo F., Benfenati E. In Silico Methods for Predicting Drug Toxicity. Springer; Berlin/Heidelberg, Germany: 2016. In silico models for repeated-dose toxicity (RDT): Prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs; pp. 163\u2013176.", "ArticleIdList": ["27311467"]}, {"Citation": "Venkatapathy R., Moudgal C.J., Bruce R.M. Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. J. Chem. Inf. Comput. Sci. 2004;44:1623\u20131629. doi: 10.1021/ci049903s.", "ArticleIdList": ["10.1021/ci049903s", "15446819"]}, {"Citation": "Wilhelmus K.R. The Draize eye test. Surv. Ophthalmol. 2001;45:493\u2013515. doi: 10.1016/S0039-6257(01)00211-9.", "ArticleIdList": ["10.1016/S0039-6257(01)00211-9", "11425356"]}, {"Citation": "Abdallah A.E., Alesawy M.S., Eissa S.I., El-Fakharany E.M., Kalaba M.H., Sharaf M.H., Abo Shama N.M., Mahmoud S.H., Mostafa A., Al-Karmalawy A.A., et al. Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening. New J. Chem. 2021;45:16557\u201316571. doi: 10.1039/D1NJ02710G.", "ArticleIdList": ["10.1039/D1NJ02710G"]}, {"Citation": "Subashchandrabose S., Saleem H., Erdogdu Y., Rajarajan G., Thanikachalam V. FT-Raman, FT-IR spectra and total energy distribution of 3-pentyl-2,6-diphenylpiperidin-4-one: DFT method. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;82:260\u2013269. doi: 10.1016/j.saa.2011.07.046.", "ArticleIdList": ["10.1016/j.saa.2011.07.046", "21862393"]}, {"Citation": "Bazeera A.Z., Selvaraj S., Mohamed A.S. Spectroscopic analysis (Raman, FT-IR, UV, NMR), HUMO, LUMO and first order hyper polarizability calculations of Nor Leucine Maleate (DLNM) using DFT methods. Wutan Huatan Jisuan Jishu. 2020;16:266\u2013277."}, {"Citation": "Mohammed H.S., Tripathi V.D., Darghouth A.A. Journal of Physics: Conference Series. IOP Publishing; Bristol, UK: 2019. Synthesis, Characterization, DFT calculation and Antimicrobial Activity of Co (II) and Cu (II) complexes with azo dye; p. 052051."}, {"Citation": "Fleming I. Frontier Orbitals and Organic Chemical Reactions. Wiley; New York, NY, USA: 1977."}, {"Citation": "El-Nahass M., Kamel M., El-Deeb A., Atta A., Huthaily S. Ab initio HF, DFT and experimental (FT-IR) investigation of vibrational spectroscopy of PN, N-dimethylaminobenzylidenemalononitrile (DBM) Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2011;79:443\u2013450. doi: 10.1016/j.saa.2011.02.055.", "ArticleIdList": ["10.1016/j.saa.2011.02.055", "21514212"]}, {"Citation": "Parambil S.H.K., Parambil H.A.T., Hamza S.P., Parameswaran A.T., Thayyil M.S., Karuvanthodi M. Density Functional Theory Calculations. IntechOpen; London, UK: 2020. DFT and Molecular Docking Studies of a Set of Non-Steroidal Anti-Inflammatory Drugs: Propionic Acid Derivatives."}, {"Citation": "Discovery Studio . Accelrys. BIOVIA; San Diego, CA, USA: 2008."}, {"Citation": "Pegu D., Deb J., Van Alsenoy C., Sarkar U. Theoretical investigation of electronic, vibrational, and nonlinear optical properties of 4-fluoro-4-hydroxybenzophenone. Spectrosc. Lett. 2017;50:232\u2013243. doi: 10.1080/00387010.2017.1308381.", "ArticleIdList": ["10.1080/00387010.2017.1308381"]}, {"Citation": "Matin M.M., Hasan M.S., Uzzaman M., Bhuiyan M.M.H., Kibria S.M., Hossain M.E., Roshid M.H. Synthesis, spectroscopic characterization, molecular docking, and ADMET studies of mannopyranoside esters as antimicrobial agents. J. Mol. Struct. 2020;1222:128821. doi: 10.1016/j.molstruc.2020.128821.", "ArticleIdList": ["10.1016/j.molstruc.2020.128821"]}, {"Citation": "Hatano T., Eerdunbayaer C., Kuroda T., Shimozu Y. Biological Activities and Action Mechanisms of Licorice Ingredients. InTech; Rijeka, Croatia: 2017. Licorice as a resource for pharmacologically active phenolic substances: Antioxidant and antimicrobial effects; pp. 59\u201375."}, {"Citation": "Uchiumi F., Hatano T., Ito H., Yoshida T., Tanuma S.-I. Transcriptional suppression of the HIV promoter by natural compounds. Antivir. Res. 2003;58:89\u201398. doi: 10.1016/S0166-3542(02)00186-9.", "ArticleIdList": ["10.1016/S0166-3542(02)00186-9", "12719011"]}, {"Citation": "Vlietinck A., De Bruyne T., Apers S., Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 1998;64:97\u2013109. doi: 10.1055/s-2006-957384.", "ArticleIdList": ["10.1055/s-2006-957384", "9525100"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "15"}, {"Year": "2022", "Month": "9", "Day": "1"}, {"Year": "2022", "Month": "9", "Day": "5"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "30"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["36143445", "PMC9505301", "10.3390/life12091407", "life12091407"]}}], "PubmedBookArticle": []}